Katalin Karikó

# **Katalin Karikó: The Scientist Who Refused to Give Up**

### *For years her grants were rejected, her work was dismissed, and her academic career went backwards. Then the world desperately needed the science she had refused to abandon.*

In 1995, Katalin Karikó faced the kind of moment that quietly ends many scientific careers.

She had spent years studying **messenger RNA—mRNA** at the University of Pennsylvania. She believed that this fragile molecule, which carries genetic instructions from DNA to the machinery that makes proteins, could someday be turned into medicine.

There was one problem.

Very few people believed her.

Her grant applications repeatedly failed. Funding was scarce. mRNA was considered too unstable, too difficult to deliver into cells and too likely to provoke harmful inflammatory reactions. Even the Nobel Committee later acknowledged that enthusiasm for therapeutic mRNA was limited because these obstacles seemed so formidable. ([Nobel Prize][1])

And then came the humiliation.

In 1995, unable to secure the funding and promotion expected in the academic system, Karikó was offered a choice at Penn: **accept a demotion or leave**.

She accepted the demotion.

That decision tells us almost everything about Katalin Karikó.

She was less interested in protecting her status than in continuing the experiment.

---

## **A Scientist From a Small Hungarian Town**

Karikó was born in **1955 in Szolnok, Hungary**, and grew up in Kisújszállás. She earned her PhD in biochemistry from the University of Szeged in 1982 and continued doing research in Hungary. ([Nobel Prize][2])

Then, in 1985, the laboratory where she worked lost its funding.

Karikó began writing letters to laboratories abroad looking for a position. Eventually, Robert Suhadolnik at Temple University in Philadelphia offered her an opportunity.

So Karikó, her husband and their two-and-a-half-year-old daughter left Hungary for America.

They were hardly arriving as privileged immigrants.

Hungarian restrictions allowed them to take very little money out of the country. Karikó later recalled that the family sold their car, exchanged the proceeds and **hid roughly $1,200 inside their daughter's teddy bear** before leaving for Philadelphia. ([PubMed Central (PMC)][3])

It has become one of the most memorable details of her story:

A young scientist crossing an ocean with her family, one-way tickets—and much of their savings hidden inside a child's toy.

There was no guarantee of success waiting on the other side.

---

## **The Molecule Nobody Wanted**

Karikó became fascinated by a deceptively simple possibility.

Every cell contains machinery capable of producing proteins. DNA holds the instructions, while messenger RNA temporarily carries those instructions to the cellular machinery.

Karikó wondered:

**Instead of giving the body a finished drug, why not give its cells instructions to make the therapeutic protein themselves?**

Today that sounds almost obvious.

Thirty years ago, it did not.

Artificially produced mRNA was fragile. The immune system could recognize it as foreign and respond with inflammation. Getting enough of it safely into cells was another major obstacle.

Yet Karikó kept returning to the same molecule.

Grant rejection followed grant rejection.

In academia, this matters enormously. Grants bring laboratories, staff, publications, promotions and prestige. Researchers whose projects repeatedly fail to attract funding usually change direction—or leave.

Karikó did neither.

She continued.

There is an important distinction here.

Persistence is not automatically a virtue. Scientists can stubbornly defend ideas that are simply wrong.

What makes Karikó's story remarkable is that she did not merely **believe harder**.

She kept experimenting.

She kept modifying her hypothesis.

She kept following the evidence.

That is scientific devotion—not faith in being right, but willingness to spend years discovering whether you are wrong.

---

## **A Photocopier Changes the Story**

Then, in 1997, something ordinary happened.

Karikó met immunologist **Drew Weissman** at a photocopy machine at the University of Pennsylvania.

Both scientists frequently copied research papers, and conversation gradually turned into collaboration.

Their interests complemented each other beautifully.

Karikó understood RNA and dreamed of using it therapeutically.

Weissman was an immunologist interested in vaccines.

Together they confronted one of mRNA's central problems: **Why did laboratory-made mRNA trigger such a strong immune reaction?** ([Penn Today][4])

Their experiments eventually revealed something profound.

The immune system was reacting to particular components of the synthetic RNA. By replacing certain RNA building blocks with **modified nucleosides**, they could dramatically reduce the unwanted inflammatory response while allowing the mRNA to produce the desired protein.

Their landmark findings were published in **2005**. ([Nobel Prize][2])

The discovery would eventually change medicine.

But not overnight.

There was no sudden Hollywood ending.

No instant Nobel Prize.

No university auditorium filled with people apologizing for having doubted her.

Science usually does not work that way.

For years, the significance of the discovery developed quietly.

---

## **Leaving the University, But Not the Idea**

In 2013, Karikó left her full-time position at Penn and joined a relatively young German biotechnology company.

Its name was **BioNTech**.

She became a vice president and later senior vice president, working there until 2022. ([Nobel Prize][5])

The scientific world was finally beginning to see what she had seen decades earlier:

mRNA was not merely an interesting biological molecule.

It could become a **platform for medicine**.

Researchers began exploring its potential for vaccines, cancer therapies and other treatments.

Then came 2020.

---

## **When the World Suddenly Needed mRNA**

A new coronavirus began spreading across the planet.

Scientists had to develop a vaccine at extraordinary speed.

Traditional approaches could take years.

But mRNA technology offered something different. Once researchers knew the genetic sequence of the virus, they could design mRNA instructing human cells to produce a harmless version of a viral protein, training the immune system to recognize the real virus.

The discoveries made by Karikó and Weissman concerning nucleoside modifications became critical foundations for the highly effective **Pfizer-BioNTech and Moderna mRNA vaccines**.

Work that had once struggled to attract grants was suddenly helping confront one of the greatest global health emergencies of modern times. ([Nobel Prize][5])

Millions of people received vaccines built upon a scientific pathway that had once seemed too impractical to pursue.

The obscure molecule had become famous.

And so had Katalin Karikó.

---

## **Then Came Stockholm**

On **October 2, 2023**, the Nobel Assembly announced that the Nobel Prize in Physiology or Medicine would be awarded jointly to **Katalin Karikó and Drew Weissman**:

> “for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.” ([Nobel Prize][6])

Consider the arc of that life.

The researcher whose laboratory in Hungary lost funding.

The immigrant who arrived in America with family savings hidden inside a teddy bear.

The scientist whose grant applications repeatedly failed.

The academic who accepted a demotion rather than abandon her research.

The woman who spent years working on a technology many regarded as impractical.

She was now standing among Nobel laureates.

But reducing her story to **“never give up and eventually you will succeed”** would actually diminish it.

Many people persist and fail.

Karikó's deeper lesson is different.

She did not spend decades chasing recognition.

She spent decades chasing a scientific question.

Recognition came much later.

---

## **Success Arrived After the Work Was Already Done**

Modern culture often measures progress through visible rewards:

promotion,

salary,

titles,

grants,

followers,

awards.

Karikó's career exposes how unreliable those measurements can sometimes be.

In one period of her life, the institutional signals surrounding her were effectively saying:

**Your work is not important enough.**

Reality eventually gave a very different verdict.

This does not mean institutions are always wrong or rejected ideas are secretly brilliant. Most rejected scientific hypotheses do not win Nobel Prizes.

But Karikó's story demonstrates something important about original work:

**The value of an idea and the recognition of that idea do not necessarily arrive at the same time.**

Sometimes they are separated by decades.

---

## **Perhaps Her Greatest Achievement Was Not the Nobel**

The Nobel Prize is the visible ending of Katalin Karikó's story.

But perhaps her greatest achievement happened much earlier.

It happened every time she walked back into the laboratory when there was no prize waiting for her.

When another grant was rejected.

When promotion disappeared.

When other scientists moved toward more fashionable research.

When mRNA remained unstable and frustrating.

When nobody knew that a pandemic was coming.

She continued because the problem itself fascinated her.

And that may be the most extraordinary form of devotion:

**to work seriously on something before the world has decided that it matters.**

In 1995, Katalin Karikó accepted a demotion so that she could keep studying mRNA.

Twenty-eight years later, she accepted the **Nobel Prize in Physiology or Medicine** for discoveries arising from that same scientific obsession.

Between those two moments lies one of the most remarkable stories in modern science.

It reminds us that sometimes failure is failure.

Sometimes rejection is justified.

But occasionally, hidden among thousands of rejected proposals and unfashionable ideas, there is a person seeing something the rest of the world has not yet learned how to see.

**Katalin Karikó kept looking.**

Eventually, the world caught up.

[1]: https://www.nobelprize.org/prizes/medicine/2023/press-release/?hss_channel=lcp-18618332&utm_source=chatgpt.com "Press release: The Nobel Prize in Physiology or Medicine 2023 - NobelPrize.org"

[2]: https://www.nobelprize.org/prizes/medicine/2023/kariko/facts/?trk=public_post_comment-text&utm_source=chatgpt.com "Katalin Karikó – Facts – 2023 - NobelPrize.org"

[3]: https://pmc.ncbi.nlm.nih.gov/articles/PMC8713962/?utm_source=chatgpt.com "QnAs with Katalin Karikó - PMC"

[4]: https://penntoday.upenn.edu/news/foundational-discoveries-pandemic-proliferation-impact-weissman-kariko?utm_source=chatgpt.com "From foundational discoveries to profound impact | Penn Today"

[5]: https://www.nobelprize.org/events/nobel-prize-dialog

ue/madrid-2024/panellists/katalin-kariko/?utm_source=chatgpt.com "Event information - NobelPrize.org"

[6]: https://www.nobelprize.org/prizes/medicine/2023/press-release/?related=1&utm_source=chatgpt.com "Press release: The Nobel Prize in Physiology or Medicine 2023 - NobelPrize.org"